The OBL Reckoning
Peripheral vascular care keeps shifting into office-based labs. A federal review signals the next phase will be judged on appropriateness, not growth.
Cardiology’s ASC Moment
CMS has opened ambulatory surgery centers to cardiac ablation and more cardiovascular work. The build-out, staffing and safety data decide who moves first.
Beyond the Heart: Why More Interventional Cardiologists Are Treating Peripheral Artery Disease
Interventional cardiology was built around the coronary arteries. ClearSight identified 1,625 interventional cardiologists now treating vascular disease far beyond the heart.
The FFR Paradox: Why the Gold Standard Isn’t the Standard Everywhere
FFR is one of the most validated technologies in interventional cardiology, yet its use is anything but even. ClearSight analyzed 185,373 procedures to see who actually adopts it.